Loading company…
Phoenix-based biotech developing immuno-oncology therapies that deliver multiple cancer-killing payloads for targeted treatment.
OncoMyx, Inc. was founded in 2018 and is headquartered in Phoenix, US. Led by CEO Steven Potts, it develops a novel immuno-oncology platform that delivers multiple cancer-killing payloads for various cancers. In November 2021 it raised USD 50 mn in a Series B round from investors including B Capital Group and Lumira Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in